David Emerson Jorden, Director at CYTOMEDIX INC (CMXI), bought 50,000 shares at $0.51 ($25K) on 2013-04-17, disclosed to the SEC on 2013-04-19.
Open-market purchase of $25k CMXI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.51 | 15,000 | $8K | 30.2% |
| 2 | $0.51 | 20,000 | $10K | 40.2% |
| 3 | $0.50 | 15,000 | $8K | 29.6% |
| Total | $0.51 avg | 50,000 | $25K | 100% |
| Filing → |
| AURX | BUY | 2017-08-14 | $54K | — | Filing → |
| PLXP | BUY | 2017-06-16 | $450K | — | Filing → |
| PrivateNuo Therapeutics, Inc. | BUY | 2016-07-29 | $138K | — | Filing → |